{"id":"asthma-reliever-therapies","safety":{"commonSideEffects":[{"rate":null,"effect":"Tremor"},{"rate":null,"effect":"Tachycardia"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nervousness"}]},"_chembl":{"chemblId":"CHEMBL3306803","moleculeType":"Small molecule","molecularWeight":"393.51"},"_fixedAt":"2026-03-30T13:11:00.538644","_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is a broad therapeutic category rather than a single drug entity. Sanofi's asthma reliever therapies in Phase 3 likely include bronchodilators or other agents designed to provide rapid symptom relief during asthma attacks. The specific mechanism depends on the individual compound within this program, which may target beta-2 adrenergic receptors, muscarinic receptors, or other pathways involved in airway smooth muscle relaxation.","oneSentence":"Asthma Reliever Therapies from Sanofi work to rapidly open airways and reduce airway constriction in asthma patients.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:02:48.736Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Asthma symptom relief"}]},"_fixedFields":["pubmed(7)"],"trialDetails":[{"nctId":"NCT03890666","phase":"PHASE4","title":"A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2020-10-26","conditions":"Asthma","enrollment":333},{"nctId":"NCT06473779","phase":"PHASE3","title":"Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2024-09-30","conditions":"Severe Asthma","enrollment":326},{"nctId":"NCT06596512","phase":"NA","title":"Improving the Quality of Care for Asthma Patients at Risk of Exacerbations","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-07","conditions":"Asthma, Asthma Chronic, Asthma Severe Persistent With Exacerbation","enrollment":4100},{"nctId":"NCT05168995","phase":"","title":"Effects of Beclometasone Dipropionate/Formoterol Fumarate Via NEXT(Haler) in a Real-world Study on Asthma Control","status":"COMPLETED","sponsor":"Chiesi Italia","startDate":"2022-04-12","conditions":"Asthma","enrollment":620},{"nctId":"NCT06796387","phase":"NA","title":"SMART-School-based Asthma Therapy","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2026-12","conditions":"Asthma in Children","enrollment":330},{"nctId":"NCT07241117","phase":"PHASE4","title":"CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2026-01-06","conditions":"Moderate to Severe Asthma","enrollment":2000},{"nctId":"NCT06429475","phase":"PHASE3","title":"Anti-Inflammatory Reliever South Africa","status":"RECRUITING","sponsor":"University of KwaZulu","startDate":"2024-06-06","conditions":"Asthma","enrollment":1038},{"nctId":"NCT03560466","phase":"PHASE3","title":"Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-06-21","conditions":"Asthma","enrollment":378},{"nctId":"NCT07052942","phase":"PHASE4","title":"Individualizing Treatment for Asthma in Primary Care (Full Study)","status":"RECRUITING","sponsor":"DARTNet Institute","startDate":"2025-08-01","conditions":"Asthma, Asthma Attack, Asthma Exacerbations","enrollment":3200},{"nctId":"NCT07138027","phase":"NA","title":"SMART Implementation-Effectiveness Trial 2","status":"RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2025-09-03","conditions":"Asthma in Children","enrollment":18},{"nctId":"NCT06902766","phase":"NA","title":"Towards Digital Management of Paediatric Asthma","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-10","conditions":"Pediatric Asthma","enrollment":50},{"nctId":"NCT07025616","phase":"NA","title":"Effects of Buteyko Breathing Exercise in Children With Uncontrolled Asthma","status":"NOT_YET_RECRUITING","sponsor":"Ivan Sofian Wibowo","startDate":"2025-06","conditions":"Breathing Techniques, Asthma Control Level, Asthma in Children","enrollment":74},{"nctId":"NCT06272370","phase":"PHASE4","title":"Individualizing Treatment for Asthma in Primary Care","status":"COMPLETED","sponsor":"DARTNet Institute","startDate":"2024-02-01","conditions":"Asthma, Bronchial Diseases, Respiratory Tract Infections","enrollment":103},{"nctId":"NCT03924635","phase":"PHASE4","title":"An Exploratory Study to Characterise Changes in Airway Inflammation, Symptoms, Lung Function and Reliever Use in Adult Asthma Patients","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2019-08-01","conditions":"Airway Inflammation, Asthma","enrollment":42},{"nctId":"NCT04159519","phase":"PHASE4","title":"A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2020-07-27","conditions":"Asthma, Severe Eosinophilic Asthma","enrollment":170},{"nctId":"NCT06568445","phase":"PHASE4","title":"Maintenance at Initial Treatment With Sequential Anti-Inflammation Reliever Therapy","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2024-08-12","conditions":"Bronchial Asthma","enrollment":90},{"nctId":"NCT04705727","phase":"PHASE3","title":"Budesonide/Formoterol Turbuhaler® Versus Terbutaline Nebulization as Reliever Therapy in Children With Moderate Asthma Exacerbation","status":"TERMINATED","sponsor":"Centre Hospitalier Intercommunal Creteil","startDate":"2021-08-23","conditions":"Asthma in Children","enrollment":102},{"nctId":"NCT03620747","phase":"PHASE3","title":"Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-08-30","conditions":"Asthma","enrollment":393},{"nctId":"NCT03782532","phase":"PHASE3","title":"Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma","status":"COMPLETED","sponsor":"Sanofi","startDate":"2019-01-25","conditions":"Asthma","enrollment":486},{"nctId":"NCT02573233","phase":"PHASE2","title":"Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-01-27","conditions":"Asthma","enrollment":42},{"nctId":"NCT02948959","phase":"PHASE3","title":"Evaluation of Dupilumab in Children With Uncontrolled Asthma","status":"COMPLETED","sponsor":"Sanofi","startDate":"2017-04-21","conditions":"Asthma","enrollment":408},{"nctId":"NCT02528214","phase":"PHASE3","title":"Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-10-15","conditions":"Asthma","enrollment":210},{"nctId":"NCT02414854","phase":"PHASE3","title":"Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-04-27","conditions":"Asthma","enrollment":1902},{"nctId":"NCT02918487","phase":"NA","title":"Role of Herbs in the Management of Asthma","status":"UNKNOWN","sponsor":"Composite Interceptive Med Science","startDate":"2016-12","conditions":"Bronchial Asthma","enrollment":38},{"nctId":"NCT01854047","phase":"PHASE2","title":"An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma","status":"COMPLETED","sponsor":"Sanofi","startDate":"2013-06","conditions":"Asthma","enrollment":776},{"nctId":"NCT00861926","phase":"PHASE3","title":"Study Comparing Foster Efficacy Maintenance and Reliever Versus Foster Maintenance + Salbutamol Reliever in Asthmatics","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2009-03","conditions":"Asthma","enrollment":2079},{"nctId":"NCT01711840","phase":"","title":"Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2012-11","conditions":"Bronchial Asthma","enrollment":2409},{"nctId":"NCT00858286","phase":"PHASE4","title":"A Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT, SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-02","conditions":"Asthma","enrollment":56},{"nctId":"NCT00939341","phase":"PHASE4","title":"Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across Asia","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2009-07","conditions":"Asthma","enrollment":862},{"nctId":"NCT01313585","phase":"","title":"Device Mixing in Asthma, a General Practice Research Database Study","status":"COMPLETED","sponsor":"Research in Real-Life Ltd","startDate":"1991-01","conditions":"Asthma","enrollment":815377},{"nctId":"NCT00937066","phase":"","title":"Cost-effectiveness Study of Symbicort as Maintenance and Reliever Therapy (SMART)","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"","conditions":"Asthma","enrollment":1000},{"nctId":"NCT00576316","phase":"PHASE4","title":"Symbicort Maintenance and Reliever Therapy - Experience in Real Life Setting in Malaysia","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2008-01","conditions":"Asthma","enrollment":201},{"nctId":"NCT00800241","phase":"","title":"Budesonide/Formoterol for Maintenance and Reliever Therapy Among Asthma Patients in Thailand","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2009-05","conditions":"Asthma","enrollment":1020},{"nctId":"NCT00785733","phase":"","title":"NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2008-11","conditions":"Moderate/Severe Asthma","enrollment":1182},{"nctId":"NCT00573222","phase":"","title":"Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2007-11","conditions":"Asthma","enrollment":330},{"nctId":"NCT00782314","phase":"","title":"Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2008-04","conditions":"Asthma","enrollment":400},{"nctId":"NCT00523679","phase":"","title":"Symbicort SMART (Symbicort Maintenance And Reliever Therapy)","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2007-07","conditions":"Asthma","enrollment":2000},{"nctId":"NCT00524641","phase":"","title":"Asthma Control-A \"Patient Follow up Programme\" Maintenance and Reliever Therapy in a Single Inhaler","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2007-07","conditions":"Asthma","enrollment":1254},{"nctId":"NCT00557297","phase":"","title":"NIS for Patients Using Symbicort Turbuhaler for Maintenance and Reliever Therapy in a Single Inhaler","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2007-10","conditions":"Asthma","enrollment":250}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"recentPublications":[{"date":"2025 Jul","pmid":"40349963","title":"Optimizing Pediatric Asthma Management: Implementation and Evaluation of Anti-Inflammatory Reliever and Single Maintenance and Reliever Therapies.","journal":"The journal of allergy and clinical immunology. In practice"},{"date":"2025 Jan 14","pmid":"39465893","title":"Inhaled Reliever Therapies for Asthma: A Systematic Review and Meta-Analysis.","journal":"JAMA"},{"date":"2023 May 1","pmid":"36994505","title":"As-needed inhaled corticosteroids as add-on therapy versus SMART therapy: an evolving understanding of the two approaches in the management of moderate-to-severe asthma.","journal":"Current opinion in pulmonary medicine"},{"date":"2020 Jun","pmid":"32500439","title":"Sustainability in Inhaled Drug Delivery.","journal":"Pharmaceutical medicine"},{"date":"2019 Jan 28","pmid":"30687940","title":"School-based self-management interventions for asthma in children and adolescents: a mixed methods systematic review.","journal":"The Cochrane database of systematic reviews"}],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Asthma Reliever Therapies","genericName":"Asthma Reliever Therapies","companyName":"Sanofi","companyId":"sanofi","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Asthma Reliever Therapies from Sanofi work to rapidly open airways and reduce airway constriction in asthma patients. Used for Asthma symptom relief.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":2,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}